C. Mertens

3.0k total citations · 2 hit papers
43 papers, 1.9k citations indexed

About

C. Mertens is a scholar working on Oncology, Geriatrics and Gerontology and Physiology. According to data from OpenAlex, C. Mertens has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Geriatrics and Gerontology and 14 papers in Physiology. Recurrent topics in C. Mertens's work include Frailty in Older Adults (14 papers), Nutrition and Health in Aging (14 papers) and Head and Neck Cancer Studies (7 papers). C. Mertens is often cited by papers focused on Frailty in Older Adults (14 papers), Nutrition and Health in Aging (14 papers) and Head and Neck Cancer Studies (7 papers). C. Mertens collaborates with scholars based in France, Monaco and United States. C. Mertens's co-authors include Pierre Soubeyran, M. Rainfray, Carine Bellera, Simone Mathoulin‐Pélissier, Marianne Fonck, Fleur Delva, J. Ceccaldi, C. Blanc-Bisson, Jean‐Frédéric Blanc and Jérôme Dauba and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

C. Mertens

38 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening older cancer patients: first evaluation of the G-8 geriatric screening tool

2012 669 citations Carine Bellera, M. Rainfray et al. Annals of Oncology profile →
Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

2014 368 citations Pierre Soubeyran, Carine Bellera et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Mertens France	12	1.0k	741	629	513	336	43	1.9k
Philippe Caillet France	21	844 0.8×	697 0.9×	491 0.8×	357 0.7×	276 0.8×	80	1.6k
Kurt Hansen United States	7	923 0.9×	499 0.7×	760 1.2×	463 0.9×	206 0.6×	9	1.8k
S. Klapper United States	5	708 0.7×	387 0.5×	561 0.9×	327 0.6×	157 0.5×	7	1.3k
Ronald J. Maggiore United States	21	521 0.5×	216 0.3×	532 0.8×	330 0.6×	149 0.4×	46	1.2k
Catherine Handforth United Kingdom	7	520 0.5×	377 0.5×	293 0.5×	231 0.5×	143 0.4×	14	871
Jingjie Xiao Canada	23	615 0.6×	1.4k 1.9×	841 1.3×	222 0.4×	387 1.2×	45	2.1k
Frédéric Pamoukdjian France	14	363 0.3×	472 0.6×	285 0.5×	207 0.4×	132 0.4×	42	917
Cecilia G. Ethun United States	21	268 0.3×	200 0.3×	674 1.1×	600 1.2×	524 1.6×	74	1.4k
Nimit Singhal Australia	18	336 0.3×	103 0.1×	376 0.6×	255 0.5×	178 0.5×	69	1.0k
Jeroen L.A. van Vugt Netherlands	26	703 0.7×	1.7k 2.2×	848 1.3×	477 0.9×	1.0k 3.1×	56	2.7k

Countries citing papers authored by C. Mertens

Since Specialization

Citations

This map shows the geographic impact of C. Mertens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mertens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mertens more than expected).

Fields of papers citing papers by C. Mertens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Mertens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mertens. The network helps show where C. Mertens may publish in the future.

Co-authorship network of co-authors of C. Mertens

This figure shows the co-authorship network connecting the top 25 collaborators of C. Mertens. A scholar is included among the top collaborators of C. Mertens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Mertens. C. Mertens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grellety, Thomas, Carine Bellera, Coralie Cantarel, et al.. (2025). Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study. Journal of Geriatric Oncology. 102812–102812.

Martinez‐Tapia, Claudia, Tristan Cudennec, Chérifa Taleb, et al.. (2023). Prevalence of Four Sarcopenia Criteria in Older Patients with Cancer, and Their Predictive Value for 6-Month Mortality: The NutriAgeCancer National Prospective Cohort Study. Nutrients. 15(6). 1508–1508. 5 indexed citations

Regueme, Sophie, J. Durrieu, C. Mertens, et al.. (2020). Protein intake, weight loss, dietary intervention, and worsening of quality of life in older patients during chemotherapy for cancer. Supportive Care in Cancer. 29(2). 687–696. 16 indexed citations

Dousset, L., C. Mertens, E. Gérard, et al.. (2020). Impact sur la qualité de vie et l’autonomie des patients de plus de 75 ans traités par anti-PD-1 pour un mélanome métastatique : étude prospective monocentrique. Annales de Dermatologie et de Vénéréologie. 147(11). 713–720. 1 indexed citations

Dutriaux, Caroline, S. Prey, E. Gérard, et al.. (2020). Adverse events, need for hospitalization and systemic immunosuppression in very older patients (over 80 years) treated with anti-PD-1 for metastatic melanoma. Journal of Geriatric Oncology. 11(8). 1340–1343. 4 indexed citations

Ortholan, Cécile, A. Aupérin, C. Mertens, H. Le Caer, & J. Guigay. (2018). Radiothérapie hypofractionnée des cancers ORL chez le sujet âgé. Cancer/Radiothérapie. 22(6-7). 640–643. 5 indexed citations

Kadan‐Lottick, Nina S., Leslie L. Robison, James G. Gurney, et al.. (2017). Childhood Cancer Survivors' Knowledge About Their Past Diagnosis and Treatment. JAMA. 287(14). 4 indexed citations

Mertens, C., H. Le Caer, Cécile Ortholan, et al.. (2017). The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit. Annals of Oncology. 28. v375–v376. 10 indexed citations

Hoppe, Stéphanie, M. Rainfray, Marianne Fonck, et al.. (2013). Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy. Journal of Clinical Oncology. 31(31). 3877–3882. 174 indexed citations

10.

Soubeyran, Pierre, Marianne Fonck, C. Blanc-Bisson, et al.. (2012). Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer. Journal of Clinical Oncology. 30(15). 1829–1834. 305 indexed citations

11.

Soubeyran, Pierre, et al.. (2012). Therapeutic strategies in elderly and very elderly patients. Best Practice & Research Clinical Haematology. 25(1). 91–100. 6 indexed citations

12.

Bellera, Carine, M. Rainfray, Simone Mathoulin‐Pélissier, et al.. (2012). Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Annals of Oncology. 23(8). 2166–2172. 669 indexed citations breakdown →

13.

Fonck, Marianne, René Brunet, Y. Bécouarn, et al.. (2011). Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: A first-line phase II study. Clinics and Research in Hepatology and Gastroenterology. 35(12). 823–830. 12 indexed citations

14.

Mertens, C., et al.. (2011). Agronomical factors influencing the legumin/vicilin ratio in pea (Pisum sativum L.) seeds. Journal of the Science of Food and Agriculture. 92(8). 1591–1596. 60 indexed citations

15.

Brain, Étienne, C. Mertens, Véronique Girre, et al.. (2010). Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial. Critical Reviews in Oncology/Hematology. 80(1). 160–170. 38 indexed citations

16.

Debled, Marc, Nicolas Madranges, C. Mertens, et al.. (2010). First-line chemotherapy for metastatic breast cancer in patients ≥75 years: A retrospective single-centre analysis. Critical Reviews in Oncology/Hematology. 80(1). 171–179. 17 indexed citations

17.

Soubeyran, Pierre, C. Mertens, Carine Bellera, Simone Mathoulin‐Pélissier, & M. Rainfray. (2009). Management of unfit patients with unfavourable non-Hodgkin’s lymphomas. Cancer Treatment Reviews. 35(6). 528–532. 3 indexed citations

18.

Mertens, C., et al.. (2009). O11 Overall survival of metastatic breast cancer patients ≥75 years treated with chemotherapy: do we know the most appropriate treatment? A French retrospective monocentric analysis. Critical Reviews in Oncology/Hematology. 72(1). S18–S18.

19.

Vlayen, Joan, et al.. (2008). Kwaliteit van rectale kankerzorg – Fase 2. 1 indexed citations

20.

Mertens, C.. (1962). Léon-H. Dupriez, Philosophie des conjonctures économiques. Revue Philosophique de Louvain. 60(68). 709–709. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact